Schedule 13D ownership disclosure
ARROWHEAD PHARMACEUTICALS INC COM
Common stock, par value $0.001 per share (the "Common Stock") · CUSIP: 04280A100
Event date: 2025-08-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sarepta Therapeutics, Inc.Reported CIK 0000873303
Shares: 0.00 · Class: 0.00%
- Sarepta Therapeutics Investments, Inc.
Shares: 0.00 · Class: 0.00%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-109461
- Form type
- SCHEDULE 13D/A
- Filer
- ARROWHEAD PHARMACEUTICALS, INC.
- CIK
- CIK 879407
- Filed
- Aug 15, 2025
- Reporting period
- Aug 13, 2025
- Description
- Schedule 13D beneficial ownership